{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:54:54Z","timestamp":1773222894739,"version":"3.50.1"},"reference-count":48,"publisher":"AVES YAYINCILIK A.\u015e.","issue":"4","license":[{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Rheumatology"],"abstract":"<jats:p>Objectives: This study aimed to determine whether there are commonly occurring hematologic causes that may lead to thrombosis in patients recently diagnosed with immunoglobulin A vasculitis (IgAV).\r\nPatients and methods: The prospective study enrolled 107 pediatric patients diagnosed with IgAV and 98 healthy age- and sex-matched controls. Patients with IgAV who were treated at a single center between February 2016 and June 2022 were evaluated for the prevalence and clinical relevance of thrombophilic gene mutations and other prothrombotic risk factors, as well as coagulation test indices. The genotypes for common mutations in prothrombin (Pt) G20210A, factor V Leiden (FVL), and methylenetetrahydrofolate reductase (MTHFR) C677T were assessed. The coagulation assays, including Pt time and activated partial thromboplastin time, and the levels of fibrinogen, factor VIII, factor IX, and von Willebrand factor antigen were analyzed. Additionally, the levels of antithrombin, protein C, and free protein S were evaluated during the disease\u2019s acute phase before initiation of anti-inflammatory drugs.\r\nResults: Seventeen of the 107 IgAV patients were excluded. Consequently, 90 children (36 males, 54 females; mean age: 10.2\u00b13.2 years; range, 3 to 18 years) diagnosed with IgAV and 98 healthy children (45 males, 53 females; mean age: 9.7\u00b13.8 years; range, 2 to 18 years) as a control group were analyzed. A statistical analysis found no significant difference between the groups in terms of indices of coagulation assays and other prothrombotic risk factors (p&gt;0.05). The mutation frequencies of the Pt G20210A, FVL, and MTHFR C677T loci among IgAV patients were not significantly different from the control group (p&gt;0.05).\r\nConclusion: Given there is no predisposition to thrombophilia and IgAV is a form of vasculitis, the cause of thrombosis among patients with IgAV may involve mechanisms related to the inflammationhemostasis cascade.<\/jats:p>","DOI":"10.46497\/archrheumatol.2024.10711","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T07:56:27Z","timestamp":1740988587000},"page":"670-678","source":"Crossref","is-referenced-by-count":1,"title":["Relationship between IgA vasculitis and prothrombotic risk factors: A prospective, case-control study"],"prefix":"10.5152","volume":"39","author":[{"family":"Cengiz Zeybek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ahmet Bolat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Orhan G\u00fcrsel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"B\u00fclent Hac\u0131hamdio\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ahmet Emin K\u00fcrek\u00e7i","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3111","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"key":"ref-1","doi-asserted-by":"crossref","unstructured":"Yalcindag A, Sundel R. Vasculitis in childhood. Curr Opin Rheumatol 2001;13:422-7. doi: 10.1097\/00002281-200109000-00014.","DOI":"10.1097\/00002281-200109000-00014"},{"key":"ref-2","doi-asserted-by":"crossref","unstructured":"Y\u0131lmaz N, Y\u00fcksel S, Becerir T, Giri\u015fgen \u0130, Ufuk F, G\u00fcrses D, et al. Myocarditis and intracardiac thrombus due to Henoch-Sch\u00f6nlein purpura: Case report and literature review. Clin Rheumatol 2021;40:1635-44. doi: 10.1007\/s10067-020-05317-8.","DOI":"10.1007\/s10067-020-05317-8"},{"key":"ref-3","doi-asserted-by":"crossref","unstructured":"Wu H, Zhang P, Lu M, Wang R, Wang M, Xia Z, et al. Henoch-Sch\u00f6nlein purpura nephritis and cerebral venous sinus thrombosis due to hereditary deficiency of antithrombin III. Indian J Pediatr 2020;87:163-4. doi: 10.1007\/s12098-019-03081-5.","DOI":"10.1007\/s12098-019-03081-5"},{"key":"ref-4","doi-asserted-by":"crossref","unstructured":"Zaidi AU, Berman B. Crossing the thrombotic threshold: Deep vein thrombosis in Henoch-Sch\u00f6nlein purpura. Clin Pediatr (Phila) 2014;53:1396-8. doi: 10.1177\/0009922814526983.","DOI":"10.1177\/0009922814526983"},{"key":"ref-5","doi-asserted-by":"crossref","unstructured":"Li L, Zhang J, Zhang Y, Ji H. Thrombosis warning in children suffering from henoch-schonlein purpura. Indian J Dermatol 2013;58:409. doi: 10.4103\/0019- 5154.117349.","DOI":"10.4103\/0019-5154.117349"},{"key":"ref-6","doi-asserted-by":"crossref","unstructured":"Topaloglu R, Bayrakci US, Cil B, Orhon D, Bakkaloglu A. Henoch-Schonlein purpura with high factor VIII levels and deep venous thrombosis: An association or coincidence? Rheumatol Int 2008;28:935-7. doi: 10.1007\/s00296-008-0542-7.","DOI":"10.1007\/s00296-008-0542-7"},{"key":"ref-7","doi-asserted-by":"crossref","unstructured":"Abend NS, Licht DJ, Spencer CH. Lupus anticoagulant and thrombosis following Henoch-Schonlein purpura. Pediatr Neurol 2007;36:345-7. doi: 10.1016\/j. pediatrneurol.2007.01.005.","DOI":"10.1016\/j.pediatrneurol.2007.01.005"},{"key":"ref-8","doi-asserted-by":"crossref","unstructured":"Monastiri K, Selmi H, Tabarki B, Yacoub M, Mahjoub T, Essoussi AS. Primary antiphospholipid syndrome presenting as complicated Henoch-Sch\u00f6nlein purpura. Arch Dis Child 2002;86:132-3. doi: 10.1136\/ adc.86.2.132.","DOI":"10.1136\/adc.86.2.132"},{"key":"ref-9","doi-asserted-by":"crossref","unstructured":"Zheng Q, He Q, Huang H, Lu M. Venous sinus thrombosis in a case of immunoglobulin A vasculitis and a systemic review of literature. Int J Rheum Dis 2023;26:539-43. doi: 10.1111\/1756-185X.14529.","DOI":"10.1111\/1756-185X.14529"},{"key":"ref-10","doi-asserted-by":"crossref","unstructured":"Sari I, Akar S, Secil M, Birlik M, Kefi A, Onen F, et al. Thrombosis and priapism in a patient with HenochSchonlein purpura. Rheumatol Int 2005;25:472-4. doi: 10.1007\/s00296-004-0532-3.","DOI":"10.1007\/s00296-004-0532-3"},{"key":"ref-11","doi-asserted-by":"crossref","unstructured":"Abebe M, Patnaik A, Miller F, Roppelt H, Wadhwa NK, Abate M, et al. Intestinal infarction and portal vein thrombosis in a patient with henoch schonlein purpura. Case Rep Rheumatol 2012;2012:672959. doi: 10.1155\/2012\/672959.","DOI":"10.1155\/2012\/672959"},{"key":"ref-12","doi-asserted-by":"crossref","unstructured":"Canpolat U, Yorgun H, Sahiner L, Kabak\u00e7i G. Myocardial infarction due to coronary thrombosis in a patient with Henoch-Sch\u00f6nlein purpura. Herz 2012;37:801-3. doi: 10.1007\/s00059-012-3597-x.","DOI":"10.1007\/s00059-012-3597-x"},{"key":"ref-13","doi-asserted-by":"crossref","unstructured":"Dagan E, Brik R, Broza Y, Gershoni-Baruch R. Henoch-Schonlein purpura: Polymorphisms in thrombophilia genes. Pediatr Nephrol 2006;21:1117- 21. doi: 10.1007\/s00467-006-0155-x.","DOI":"10.1007\/s00467-006-0155-x"},{"key":"ref-14","doi-asserted-by":"crossref","unstructured":"Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR\/PRINTO\/PRES criteria for Henoch-Sch\u00f6nlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 2010;69:798-806. doi: 10.1136\/ard.2009.116657.","DOI":"10.1136\/ard.2009.116657"},{"key":"ref-15","doi-asserted-by":"crossref","unstructured":"Ricart JM, Vay\u00e1 A, Todol\u00ed J, Calvo J, Villa P, Estell\u00e9s A, et al. Thrombophilic risk factors and homocysteine levels in Beh\u00e7et's disease in eastern Spain and their association with thrombotic events. Thromb Haemost 2006;95:618-24.","DOI":"10.1160\/TH05-10-0659"},{"key":"ref-16","doi-asserted-by":"crossref","unstructured":"Audemard-Verger A, Pillebout E, Guillevin L, Thervet E, Terrier B. IgA vasculitis (Henoch-Sh\u00f6nlein purpura) in adults: Diagnostic and therapeutic aspects. Autoimmun Rev 2015;14:579-85. doi: 10.1016\/j. autrev.2015.02.003.","DOI":"10.1016\/j.autrev.2015.02.003"},{"key":"ref-17","doi-asserted-by":"crossref","unstructured":"Schmidt M, Christiansen CF, Horv\u00e1th-Puh\u00f3 E, Glynn RJ, Rothman KJ, S\u00f8rensen HT. Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism. J Thromb Haemost 2011;9:1326- 33. doi: 10.1111\/j.1538-7836.2011.04354.x.","DOI":"10.1111\/j.1538-7836.2011.04354.x"},{"key":"ref-18","doi-asserted-by":"crossref","unstructured":"Ungprasert P, Srivali N, Wijarnpreecha K, Charoenpong P, Knight EL. Non-steroidal anti-inflammatory drugs and risk of venous thromboembolism: A systematic review and meta-analysis. Rheumatology (Oxford) 2015;54:736-42. doi: 10.1093\/rheumatology\/ keu408.","DOI":"10.1093\/rheumatology\/keu408"},{"key":"ref-19","doi-asserted-by":"crossref","unstructured":"Nusinow SR, Federici AB, Zimmerman TS, Curd JG. Increased von Willebrand factor antigen in the plasma of patients with vasculitis. Arthritis Rheum 1984;27:1405-10. doi: 10.1002\/art.1780271211.","DOI":"10.1002\/art.1780271211"},{"key":"ref-20","doi-asserted-by":"crossref","unstructured":"Woolf AD, Wakerley G, Wallington TB, Scott DG, Dieppe PA. Factor VIII related antigen in the assessment of vasculitis. Ann Rheum Dis 1987;46:441- 7. doi: 10.1136\/ard.46.6.441.","DOI":"10.1136\/ard.46.6.441"},{"key":"ref-21","doi-asserted-by":"crossref","unstructured":"Ate\u015f E, Bakkalo\u011flu A, Saat\u00e7i U, S\u00f6ylemezo\u011flu O. von Willebrand factor antigen compared with other factors in vasculitic syndromes. Arch Dis Child 1994;70:40-3. doi: 10.1136\/adc.70.1.40.","DOI":"10.1136\/adc.70.1.40"},{"key":"ref-22","doi-asserted-by":"crossref","unstructured":"Kamitsuji H, Tani K, Yasui M, Taniguchi A, Taira K, Tsukada S, et al. Activity of blood coagulation factor XIII as a prognostic indicator in patients with Henoch-Sch\u00f6nlein purpura. Efficacy of factor XIII substitution. Eur J Pediatr 1987;146:519-23. doi: 10.1007\/BF00441608.","DOI":"10.1007\/BF00441608"},{"key":"ref-23","doi-asserted-by":"crossref","unstructured":"Culic S, Jakl R, Metlicic V, Paukovic-Sekulic B, Resic B, Culic V, et al. Platelet function analysis in children with Sch\u00f6nlein-Henoch syndrome. Arch Med Res 2001;32:268-72. doi: 10.1016\/s0188- 4409(01)00282-x.","DOI":"10.1016\/S0188-4409(01)00282-X"},{"key":"ref-24","doi-asserted-by":"crossref","unstructured":"De Mattia D, Penza R, Giordano P, Del Vecchio GC, Aceto G, Altomare M, et al. von Willebrand factor and factor XIII in children with HenochSchonlein purpura. Pediatr Nephrol 1995;9:603-5. doi: 10.1007\/BF00860949.","DOI":"10.1007\/BF00860949"},{"key":"ref-25","unstructured":"Besbas N, Erbay A, Saat\u00e7i U, Ozdemir S, Bakkaloglu A, Ozen S, et al. Thrombomodulin, tissue plasminogen activator and plasminogen activator inhibitor-1 in Henoch-Sch\u00f6nlein purpura. Clin Exp Rheumatol 1998;16:95-8."},{"key":"ref-26","doi-asserted-by":"crossref","unstructured":"Yilmaz D, Kavakli K, Ozkayin N. The elevated markers of hypercoagulability in children with Henoch-Sch\u00f6nlein purpura. Pediatr Hematol Oncol 2005;22:41-8. doi: 10.1080\/08880010590896251.","DOI":"10.1080\/08880010590896251"},{"key":"ref-27","doi-asserted-by":"crossref","unstructured":"Brendel-M\u00fcller K, Hahn A, Schneppenheim R, Santer R. Laboratory signs of activated coagulation are common in Henoch-Sch\u00f6nlein purpura. Pediatr Nephrol 2001;16:1084-8. doi: 10.1007\/ s004670100033.","DOI":"10.1007\/s004670100033"},{"key":"ref-28","doi-asserted-by":"crossref","unstructured":"Prandota J, Pankow-Prandota L, Kotecki L. Impaired activation of the fibrinolytic system in children with Henoch-Sch\u00f6nlein purpura: Beneficial effect of hydrocortisone plus Sigmaaminocaproic acid therapy on disappearance rate of cutaneous vasculitis and fibrinolysis. Am J Ther 2001;8:11-9. doi: 10.1097\/00045391- 200101000-00004.","DOI":"10.1097\/00045391-200101000-00004"},{"key":"ref-29","unstructured":"Tanaka H, Tanaka T, Tokuda O, Yamamoto H, Matsunoshita N, Takenaka K, et al. Association between Factor XIII Activity and Clinical Course in Pediatric Patients with Immunoglobulin A Vasculitis. Kobe J Med Sci 2023;69:E57-63."},{"key":"ref-30","doi-asserted-by":"crossref","unstructured":"Henriksson P, Hedner U, Nilsson IM. Factor XIII (fibrin stabilising factor) in Henoch-Sch\u00f6nlein's purpura. Acta Paediatr Scand 1977;66:273-7. doi: 10.1111\/j.1651- 2227.1977.tb07893.x.","DOI":"10.1111\/j.1651-2227.1977.tb07893.x"},{"key":"ref-31","doi-asserted-by":"crossref","unstructured":"Margetic S. Inflammation and haemostasis. Biochem Med (Zagreb) 2012;22:49-62.","DOI":"10.11613\/BM.2012.006"},{"key":"ref-32","doi-asserted-by":"crossref","unstructured":"Levi M, van der Poll T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 2005;15:254-9. doi: 10.1016\/j.tcm.2005.07.004.","DOI":"10.1016\/j.tcm.2005.07.004"},{"key":"ref-33","doi-asserted-by":"crossref","unstructured":"Onur E, Kabaroglu C, Inanir I, Var A, Guvenc Y, Gunay O, et al. Oxidative stress impairs endothelial nitric oxide levels in Beh\u00e7ets' disease. Cutan Ocul Toxicol 2011;30:217-20. doi: 10.3109\/15569527.2011.554480.","DOI":"10.3109\/15569527.2011.554480"},{"key":"ref-34","doi-asserted-by":"crossref","unstructured":"Zhong W, Zhou TB, Jiang Z. Association of endothelial nitric oxide synthase gene polymorphism with the risk of Henoch-Sch\u00f6nlein purpura\/Henoch-Sch\u00f6nlein purpura nephritis. Ren Fail 2015;37:372-6. doi: 10.3109\/0886022X.2014.1000802.","DOI":"10.3109\/0886022X.2014.1000802"},{"key":"ref-35","unstructured":"Amoli MM, Garcia-Porrua C, Calvi\u00f1o MC, Ollier WE, Gonzalez-Gay MA. Lack of association between endothelial nitric oxide synthase polymorphisms and Henoch-Sch\u00f6nlein purpura. J Rheumatol 2004;31:299-301."},{"key":"ref-36","doi-asserted-by":"crossref","unstructured":"Owens AP 3rd, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res 2011;108:1284- 97. doi: 10.1161\/CIRCRESAHA.110.233056.","DOI":"10.1161\/CIRCRESAHA.110.233056"},{"key":"ref-37","doi-asserted-by":"crossref","unstructured":"Macey M, Hagi-Pavli E, Stewart J, Wallace GR, Stanford M, Shirlaw P, et al. Age, gender and diseaserelated platelet and neutrophil activation ex vivo in whole blood samples from patients with Beh\u00e7et's disease. Rheumatology (Oxford) 2011;50:1849-59. doi: 10.1093\/rheumatology\/ker177.","DOI":"10.1093\/rheumatology\/ker177"},{"key":"ref-38","doi-asserted-by":"crossref","unstructured":"Weidner S, Hafezi-Rachti S, Rupprecht HD. Thromboembolic events as a complication of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2006;55:146-9. doi: 10.1002\/art.21704.","DOI":"10.1002\/art.21704"},{"key":"ref-39","unstructured":"Sebastian JK, Voetsch B, Stone JH, Romay-Penabad Z, Lo GH, Allen NB, et al. The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event. J Rheumatol 2007;34:2446-50."},{"key":"ref-40","doi-asserted-by":"crossref","unstructured":"Jennette JC, Falk RJ, Hu P, Xiao H. Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol 2013;8:139- 60. doi: 10.1146\/annurev-pathol-011811-132453.","DOI":"10.1146\/annurev-pathol-011811-132453"},{"key":"ref-41","doi-asserted-by":"crossref","unstructured":"Chen XQ, Tu L, Zou JS, Zhu SQ, Zhao YJ, Qin YH. The involvement of neutrophil extracellular traps in disease activity associated with IgA vasculitis. Front Immunol 2021;12:668974. doi: 10.3389\/ fimmu.2021.668974.","DOI":"10.3389\/fimmu.2021.668974"},{"key":"ref-42","doi-asserted-by":"crossref","unstructured":"Wang CL, Wu YT, Liu CA, Lin MW, Lee CJ, Huang LT, et al. Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease. Pediatrics 2003;111:E140-7. doi: 10.1542\/peds.111.2.e140.","DOI":"10.1542\/peds.111.2.e140"},{"key":"ref-43","doi-asserted-by":"crossref","unstructured":"Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003;23:2131-7. doi: 10.1161\/01. ATV.0000095974.95122.EC.","DOI":"10.1161\/01.ATV.0000095974.95122.EC"},{"key":"ref-44","doi-asserted-by":"crossref","unstructured":"Henn V, Slupsky JR, Gr\u00e4fe M, Anagnostopoulos I, F\u00f6rster R, M\u00fcller-Berghaus G, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391:591-4. doi: 10.1038\/35393.","DOI":"10.1038\/35393"},{"key":"ref-45","doi-asserted-by":"crossref","unstructured":"Turkoz Y, Evereklioglu C, Ozkiri\u015f A, Mistik S, Borlu M, Ozerol IH, et al. Serum levels of soluble P-selectin are increased and associated with disease activity in patients with Beh\u00e7et's syndrome. Mediators Inflamm 2005;2005:237-41. doi: 10.1155\/MI.2005.237.","DOI":"10.1155\/MI.2005.237"},{"key":"ref-46","doi-asserted-by":"crossref","unstructured":"Falati S, Liu Q, Gross P, Merrill-Skoloff G, Chou J, Vandendries E, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003;197:1585-98. doi: 10.1084\/jem.20021868.","DOI":"10.1084\/jem.20021868"},{"key":"ref-47","doi-asserted-by":"crossref","unstructured":"Meier TR, Myers DD Jr, Wrobleski SK, Zajkowski PJ, Hawley AE, Bedard PW, et al. Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation. Thromb Haemost 2008;99:343-51. doi: 10.1160\/TH07-10-0608.","DOI":"10.1160\/TH07-10-0608"},{"key":"ref-48","doi-asserted-by":"crossref","unstructured":"Gok F, Ugur Y, Ozen S, Dagdeviren A. Pathogenesisrelated adhesion molecules in Henoch-Schonlein vasculitis. Rheumatol Int 2008;28:313-6. doi: 10.1007\/s00296-007-0437-z.","DOI":"10.1007\/s00296-007-0437-z"}],"container-title":["Archives of Rheumatology"],"original-title":[],"link":[{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/download\/1460\/2612","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/download\/1460\/2613","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/download\/1460\/2612","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T08:59:40Z","timestamp":1761209980000},"score":1,"resource":{"primary":{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/view\/1460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,12,31]]}},"URL":"https:\/\/doi.org\/10.46497\/archrheumatol.2024.10711","relation":{},"ISSN":["2618-6500"],"issn-type":[{"value":"2618-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,31]]}}}